These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 28393043)

  • 1. Leber's congenital amaurosis and the role of gene therapy in congenital retinal disorders.
    Sharif W; Sharif Z
    Int J Ophthalmol; 2017; 10(3):480-484. PubMed ID: 28393043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Retinal Dystrophy.
    Hohman TC
    Handb Exp Pharmacol; 2017; 242():337-367. PubMed ID: 28035529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.
    Maguire AM; High KA; Auricchio A; Wright JF; Pierce EA; Testa F; Mingozzi F; Bennicelli JL; Ying GS; Rossi S; Fulton A; Marshall KA; Banfi S; Chung DC; Morgan JI; Hauck B; Zelenaia O; Zhu X; Raffini L; Coppieters F; De Baere E; Shindler KS; Volpe NJ; Surace EM; Acerra C; Lyubarsky A; Redmond TM; Stone E; Sun J; McDonnell JW; Leroy BP; Simonelli F; Bennett J
    Lancet; 2009 Nov; 374(9701):1597-605. PubMed ID: 19854499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5 years after vector administration.
    Simonelli F; Maguire AM; Testa F; Pierce EA; Mingozzi F; Bennicelli JL; Rossi S; Marshall K; Banfi S; Surace EM; Sun J; Redmond TM; Zhu X; Shindler KS; Ying GS; Ziviello C; Acerra C; Wright JF; McDonnell JW; High KA; Bennett J; Auricchio A
    Mol Ther; 2010 Mar; 18(3):643-50. PubMed ID: 19953081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal human ocular degeneration occurs in Leber's congenital amaurosis (LCA2).
    Porto FB; Perrault I; Hicks D; Rozet JM; Hanoteau N; Hanein S; Kaplan J; Sahel JA
    J Gene Med; 2002; 4(4):390-6. PubMed ID: 12124981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nature of the visual loss in observers with Leber's congenital amaurosis caused by specific mutations in RPE65.
    Ripamonti C; Henning GB; Ali RR; Bainbridge JW; Robbie SJ; Sundaram V; Luong VA; van den Born LI; Casteels I; de Ravel TJ; Moore AT; Stockman A
    Invest Ophthalmol Vis Sci; 2014 Sep; 55(10):6817-28. PubMed ID: 25257057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of gene transfer for Leber's congenital amaurosis.
    Maguire AM; Simonelli F; Pierce EA; Pugh EN; Mingozzi F; Bennicelli J; Banfi S; Marshall KA; Testa F; Surace EM; Rossi S; Lyubarsky A; Arruda VR; Konkle B; Stone E; Sun J; Jacobs J; Dell'Osso L; Hertle R; Ma JX; Redmond TM; Zhu X; Hauck B; Zelenaia O; Shindler KS; Maguire MG; Wright JF; Volpe NJ; McDonnell JW; Auricchio A; High KA; Bennett J
    N Engl J Med; 2008 May; 358(21):2240-8. PubMed ID: 18441370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of two point mutations of RPE65 from Leber's congenital amaurosis on the stability, subcellular localization and isomerohydrolase activity of RPE65.
    Chen Y; Moiseyev G; Takahashi Y; Ma JX
    FEBS Lett; 2006 Jul; 580(17):4200-4. PubMed ID: 16828753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Multifunctional Lipid ECO Plasmid DNA Nanoparticles as Efficient Non-viral Gene Therapy for Leber's Congenital Amaurosis.
    Sun D; Sahu B; Gao S; Schur RM; Vaidya AM; Maeda A; Palczewski K; Lu ZR
    Mol Ther Nucleic Acids; 2017 Jun; 7():42-52. PubMed ID: 28624218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voretigene Neparvovec and Gene Therapy for Leber's Congenital Amaurosis: Review of Evidence to Date.
    Padhy SK; Takkar B; Narayanan R; Venkatesh P; Jalali S
    Appl Clin Genet; 2020; 13():179-208. PubMed ID: 33268999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subretinal Injection of Voretigene Neparvovec-rzyl in a Patient With RPE65-Associated Leber's Congenital Amaurosis.
    Hussain RM; Tran KD; Maguire AM; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):661-663. PubMed ID: 31671202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Amelioration of Cone Survival and Vision in a Mouse Model for Leber Congenital Amaurosis.
    Li S; Samardzija M; Yang Z; Grimm C; Jin M
    J Neurosci; 2016 May; 36(21):5808-19. PubMed ID: 27225770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lentiviral gene transfer of RPE65 rescues survival and function of cones in a mouse model of Leber congenital amaurosis.
    Bemelmans AP; Kostic C; Crippa SV; Hauswirth WW; Lem J; Munier FL; Seeliger MW; Wenzel A; Arsenijevic Y
    PLoS Med; 2006 Oct; 3(10):e347. PubMed ID: 17032058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and Characterization of Induced Pluripotent Stem Cells and Retinal Organoids From a Leber's Congenital Amaurosis Patient With Novel
    Li G; Gao G; Wang P; Song X; Xu P; Xie B; Zhou T; Pan G; Peng F; Zhang Q; Ge J; Zhong X
    Front Mol Neurosci; 2019; 12():212. PubMed ID: 31572124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological characterization of gene response in Rpe65-/- mouse model of Leber's congenital amaurosis during progression of the disease.
    Cottet S; Michaut L; Boisset G; Schlecht U; Gehring W; Schorderet DF
    FASEB J; 2006 Oct; 20(12):2036-49. PubMed ID: 17012256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gene therapy revolution in ophthalmology.
    Al-Saikhan FI
    Saudi J Ophthalmol; 2013 Apr; 27(2):107-11. PubMed ID: 24227970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for eye as regenerative medicine? Lessons from RPE65 gene therapy for Leber's Congenital Amaurosis.
    Rakoczy EP; Narfström K
    Int J Biochem Cell Biol; 2014 Nov; 56():153-7. PubMed ID: 25286304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy for inherited retinal diseases.
    Nuzbrokh Y; Ragi SD; Tsang SH
    Ann Transl Med; 2021 Aug; 9(15):1278. PubMed ID: 34532415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.
    Stein L; Roy K; Lei L; Kaushal S
    Expert Opin Biol Ther; 2011 Mar; 11(3):429-39. PubMed ID: 21299439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene therapy for inherited retinal and optic nerve degenerations.
    Moore NA; Morral N; Ciulla TA; Bracha P
    Expert Opin Biol Ther; 2018 Jan; 18(1):37-49. PubMed ID: 29057663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.